DUBLIN–(BUSINESS WIRE)–The “Mesenchymal Stem Cells – Advances and Applications, 2021” report has been added to ResearchAndMarkets.com’s offering.
As the most common stem cell type being used within regenerative medicine today, there is huge potential for growth within the MSC market. There are more than one-hundred thousand scientific publications published about MSCs, as well as over 1,100 MSC clinical trials underway worldwide.
Current “hotspots” for MSC clinical trials include the U.S., E.U., China, Middle East, and South Korea. While many early-stage MSC trials have demonstrated safety and efficacy, only a small number of MSC products have reached commercialization, indicating that the therapeutic market for MSCs remains early-stage.
Population aging and an increasing prevalence of chronic disease are also driving interest in MSC-based therapies. Furthermore, Google Trend data reveals that MSC searches are more than twice as common as the next most common stem cell type. The demand for both MSCs and MSC-based research products have surged in recent years.
Today in 2021, nearly one-hundred different market competitors are developing various types of MSC-related products/services, therapies, and manufacturing technologies. Within this ever-changing landscape, having a thorough understanding of the competition and their relative strengths and weaknesses is essential.
Therefore, this global strategic report details the activities of 98 leading MSC companies. It also presents detailed market size figures for the global MSC market, segmented by geography and business segment, accompanied by five-year forecasts through 2027.
With the competitive nature of this global market, you do not have the time to do the research. Claim this report to become immediately informed, without sacrificing hours of unnecessary research or missing critical opportunities.
The main objectives of this report are to provide the reader with the following details:
- Market size determination for the global MSC market, segmented by geography and business segment
- Five-year forecasts for the global MSC market
- Details of the product candidates being developed by MSC companies
- MSC market trends, opportunities, risks, and competitive dynamics
- Major diseases addressed by MSCs in the ongoing clinical trials
- Cost of manufacturing autologous and allogeneic MSCs
- Consumption of MSCs for academic research, clinical trials, product development, and exosome production
- Trend rate data for MSC scientific publications
- Rates, quantities, geographic locations, and types of MSC clinical trials
- Types and sources of MSC industry funding
- Recent business developments related to MSCs
- MSC-based products with marketing approval and the companies commercializing them
- Currently marketed MSC-based bone matrices
- Pricing comparison of MSC-based products with marketing approval
- Emerging applications for MSCs, including genetic modification, 3D bioprinting, clean meat production, and cosmeceuticals
- Company profiles for 98 MSC market competitors, including their proprietary technologies and products/services under development
Key Topics Covered:
1. Report Overview
2. Mesechymal Stem Cells (MSCs): An Overview
3. Manufacture Of Mesenchymal Stem Cells
4. Comparison Of Autologous And Allogeneic MSC Manufacture
5. Small Scale Processing of MSCs
6. Large-Scale Expansion of MSCs
7. Estimated Consumption of MSCs In The Industry
8. Published Scientific Papers On MSCs
9. Clinical Trials of MSCs, MSC-Based COVID-19, MSC-Exosomes
10. Current Sub-Optimal Clinical Outcomes & Solutions
11. Modification of MSCs
12. Major Diseases Addressed By MSCs In Clinical Trials
13. Present Status Of Mesenchymal Stem Cell Industry
14. Market Analysis
15. Company Profiles
- 101 Bio
- Adipomics, Inc.
- Aegle Therapeutics
- Aethlon Medical, Inc.
- AgeX Therapeutics, Inc.
- Alexerion Biotech Corp.
- AlloSource, Inc.
- American CryoStem Corporation
- American Type Culture Collection (ATCC)
- AMS Biotechnology, Ltd. (AMSBIO)
- Anemocyte S.r.l
- Anjarium Biosciences
- Anterogen, Co., Ltd.
- Apceth Biopharma GmbH
- Aruna Bio
- Athersys, Inc.
- Avalon GloboCare Corp.
- Axol Bioscience, Ltd.
- Azymus Therapeutics
- Baylx, Inc.
- BioEden
- Bio-Techne
- BioCat GmbH
- BioFluidica
- BioVision, Inc.
- BrainStorm Cell Therapeutics
- Capricor Therapeutics
- Catalent Pharma Solutions
- CCRM
- CellResearch Corporation, Pte Ltd.
- Celularity, Inc
- Celltex Therapeutics Corporation
- Ciloa
- CO-DON AG
- Codiak Biosciences
- Cognate BioServices, Inc.
- Corestem, Inc.
- Creative Bioarray
- Creative Biolabs
- Cynata Therapeutics, Ltd.
- DePuy Synthes
- Direct Biologics
- EVerZom
- Evox Therapeutics, Ltd.
- Exerkine Corp.
- ExoCan Healthcare Technologies, Pvt. Ltd.
- ExoCoBio, Co., Ltd.
- Exogenus Therapeutics
- EXoPERT
- Exopharm
- Exosome Diagnostics, Inc.
- Exosome Sciences
- ExosomePlus
- Exosomics S.p.A
- Fraunhofer Institute for Cell Therapy and Immunology
- HansaBioMed Life Sciences, Ltd.
- Hope Biosciences, LLC
- Japan Tissue Engineering, Co., Ltd.
- JCR Pharmaceuticals, Co., Ltd.
- Kimera Labs, Inc.
- Lonza Group Ltd.
- Mantra Bio
- MDimune
- Medipost, Co., Ltd.
- NanoSomix, Inc.
- NanoView Biosciences
- NeurExo Sciences
- Nipro Corporation
- Novus Biologicals, LLC
- NuVasive, Inc.
- OmniSpirant Limited
- Orthocell, Ltd.
- Orthofix Medical, Inc.
- Osiris Therapeutics, Inc.
- Pharmicell, Co., Ltd.
- Pluristem Therapeutics, Inc.
- Regeneus, Ltd.
- Regenexx
- Regrow Biosciences, Pvt., Ltd.
- ReNeuron
- RoosterBio
- RoslinCT
- RTI Surgical, Inc.
- Sentien Biotechnologies, Inc.
- STEMCELL Technologies, Inc.
- Stemedica Cell Technologies, Inc.
- Stemmatters Biotechnologia e Medicina Regenerative SA
- Stempeutics Research, Pvt., Ltd.
- System Biosciences, LLC
- Takeda Pharmaceuticals U.S.A., Inc.
- Tavec Pharma
- Tempo Bioscience
- United Therapeutics Corp.
- Vericel Corporation
- Versatope Therapeutics
- Vesigen Therapeutics, Inc.
- Waisman Biomanufacturing
- WuXi Advanced Therapies
- XOStem, Inc.
- Zen-Bio, Inc.
-
Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/r/iskmvz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900